Combined Ablation and Resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Evrard, Serge ^a,b   Poston, Graeme ^c   Kissmeyer Nielsen, Peter ^d   Diallo, Abou ^a   Desolneux, Grégoire ^a   Brouste, Véronique ^a   Lalet, Caroline ^a   Mortensen, Frank ^d   Stättner, Stefan ^c,e   Fenwick, Stephen ^c   Malik, Hassan ^c   Konstantinidis, Ioannis ^f   DeMatteo, Ronald ^f   D'Angelica, Michael ^f   Allen, Peter ^f   Jarnagin, William ^f   Mathoulin Pelissier, Simone ^a,b,g   Fong, Yuman ^f  

^a INSTITUT BERGONIÉ   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e PARACELSUS MEDICAL UNIVERSITY   (Austria)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g Centre of Clinical Investigation Clinical Epidemiology   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER MORTALITY; CANCER SURGERY; COLORECTAL LIVER METASTASIS; COMBINED INTRAOPERATIVE ABLATION AND RESECTION; COMPLICATION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; ADVERSE EFFECTS; CATHETER ABLATION; CLINICAL TRIAL; COLORECTAL NEOPLASMS; CONSERVATIVE TREATMENT; DISEASE COURSE; DISEASE MANAGEMENT; LIVER NEOPLASMS; LIVER RESECTION; MIDDLE AGED; MORTALITY; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; RISK FACTOR; SECONDARY; TUMOR RECURRENCE; TUMOR VOLUME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE MANAGEMENT; DISEASE PROGRESSION; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGAN SPARING TREATMENTS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84915793475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114404     Document Type: Article

References (28)

1. Garden OJ, Rees M, Poston GJ, Mirza D, Saunders M, et al. (2006) Guidelines for resection of colorectal cancer liver metastases. Gut 55 Suppl 3: iii1-iii8. 55/suppl-3/iii1 [pii]; 10.1136/gut.2006.098053 [doi].
2. Adam R, Wicherts DA, de Haas RJ, Ciacio O, Levi F, et al. (2009) Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol 27: 1829-1835.
3. Folprecht G, Gruenberger T, Bechstein WO, Raab HR, Lordick F, et al. (2010) Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 11: 38-47.
4. Cauchy F, Aussilhou B, Dokmak S, Fuks D, Gaujoux S, et al. (2012) Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases. Ann Surg 256: 746-752.
5. Dupuy DE, Fong Y, McMullen WN (2013) Image-Guided Cancer Therapy. Springer.
6. Pugalenthi A, Cutter S, Fong Y (2014) Hepatocellular Carcinoma: Evolving Role for Ablation and Resection in Treatment of Small Tumors. Advances in Surgery 48: 259-268.
7. Karanicolas PJ, Jarnagin WR, Gonen M, Tuorto S, Allen PJ, et al. (2013) Long-term Outcomes Following Tumor Ablation for Treatment of Bilateral Colorectal Liver Metastases. JAMA Surg 148: 597-601. 1685001 [pii]; 10.1001/jamasurg.2013.1431 [doi].
8. Ruers T, Punt C, Van CF, Pierie JP, Borel-Rinkes I, et al. (2012) Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol 23: 2619-2626. mds053 [pii]; 10.1093/annonc/mds053 [doi].
9. Evrard S, Rivoire M, Arnaud J, Lermite E, Bellera C, et al. (2012) Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection. Br J Surg 99: 558-565.
10. Leblanc F, Fonck M, Brunet R, Becouarn Y, Mathoulin-Pelissier S, et al. (2008) Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases. Eur J Surg Oncol 34: 185-190.
11. Evrard S, Brouste V, McKelvie-Sebileau P, Desolneux G (2013) Liver metastases in close contact to hepatic veins ablated under vascular exclusion. Eur J Surg Oncol 39: 1400-1406. S0748-7983(13)00767-1 [pii]; 10.1016/j.ejso.2013.08.028 [doi].
12. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240: 205-213.
13. Shuster JJ (1991) Median follow-up in clinical trials. J Clin Oncol 9: 191-192.
14. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observation. J Am Stat Ass 53: 457-468.
15. Gold JS, Are C, Kornprat P, Jarnagin WR, Gonen M, et al. (2008) Increased Use of Parenchymal-Sparing Surgery for Bilateral Liver Metastases From Colorectal Cancer Is Associated With Improved Mortality Without Change in Oncologic Outcome: Trends in Treatment Over Time in 440 Patients. Ann Surg 247: 109-117.
16. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, et al. (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24: 2065-2072.
17. Karoui M, Penna C, min-Hashem M, Mitry E, Benoist S, et al. (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243: 1-7.
18. DeMatteo RP, Palese C, Jarnagin WR, Sun RL, Blumgart LH, et al. (2000) Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 4: 178-184.
19. Zorzi D, Mullen JT, Abdalla EK, Pawlik TM, Andres A, et al. (2006) Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 10: 86-94.
20. Torzilli G, Procopio F, Botea F, Marconi M, Del Fabbro D, et al. (2009) One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: a feasible and effective alternative to the 2-stage approach. Surgery 146: 60-71.
21. Weichselbaum RR, Hellman S (2011) Oligometastases revisited. Nat Rev Clin Oncol 8: 378-382. nrclinonc.2011.44 [pii]; 10.1038/nrclinonc.2011.44 [doi].
22. Matsuda A, Matsumoto S, Seya T, Matsutani T, Kishi T, et al. (2013) Does Postoperative Complication Have a Negative Impact on Long-Term Outcomes Following Hepatic Resection for Colorectal Liver Metastasis?: A Meta-Analysis. Ann Surg Oncol 20: 2485-2492.
23. Sethi N, Kang Y (2011) Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat Rev Cancer 11: 735-748. nrc3125 [pii]; 10.1038/nrc3125 [doi].
24. Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, et al. (2011) High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 29: 1083-1090. JCO.2010.32.6132 [pii]; 10.1200/JCO.2010.32.6132 [doi].
25. Tzeng CW, Vauthey JN (2013) Postoperative complications and oncologic outcomes after resection of colorectal liver metastases: the importance of staying on track. Ann Surg Oncol 20: 2457-2459. 10.1245/s10434-013-2974-x [doi].
26. Abbott DE, Sohn VY, Hanseman D, Curley SA (2014) Cost-effectiveness of simultaneous resection and RFA versus 2-stage hepatectomy for bilobar colorectal liver metastases. J Surg Oncol 109: 516-520. 10.1002/jso.23539 [doi].
27. Cardona K, Donataccio D, Peter KT, Allen PJ, DeMatteo RP, et al. (2013) Treatment of Extensive Metastatic Colorectal Cancer to the Liver with Systemic and Hepatic Arterial Infusion Chemotherapy and Two-Stage Hepatic Resection: The Role of Salvage Therapy for Recurrent Disease. Ann Surg Oncol. 10.1245/s10434-013-3351-5 [doi].
28. Eltawil KM, Boame N, Mimeault R, Shabana W, Balaa FK, et al. (2014) Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases. J Surg Oncol. 10.1002/jso.23689 [doi].